GILD Dividend: Gilead Sciences Inc Yield Insights

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	29,087	28,754	27,116	27,281	27,305	24,689
Revenue Growth (YoY)	3%	6%	-1%	0%	11%	10%
Cost of Revenue	6,191	6,251	6,019	5,657	6,601	4,572
Gross Profit	22,896	22,503	21,097	21,624	20,704	20,117
Selling, General & Admin	5,793	5,933	5,537	5,267	5,246	5,151
Research & Development	5,771	5,742	5,698	4,977	5,363	5,039
Operating Expenses	11,563	11,675	11,235	10,244	10,609	10,190
Other Non Operating Income (Expenses)	90	-2	-11	76	-29	282
Pretax Income	9,886	690	6,859	5,814	8,278	1,669
Income Tax Expense	1,776	211	1,247	1,248	2,077	1,580
Net Income	8,110	480	5,665	4,592	6,225	123
Net Income Growth	6,337%	-92%	23%	-26%	4,961%	-98%
Shares Outstanding (Diluted)	1,254	1,255	1,258	1,262	1,262	1,263
Shares Change (YoY)	0%	0%	0%	0%	0%	-1%
EPS (Diluted)	6.46	0.38	4.5	3.64	4.93	0.1
EPS Growth	7,078%	-92%	24%	-26%	4,830%	-98%
Free Cash Flow	9,667	10,305	7,421	8,344	10,805	7,518
Free Cash Flow Per Share	7.7	8.21	5.89	6.61	8.56	5.95
Gross Margin	78.71%	78.26%	77.8%	79.26%	75.82%	81.48%
Operating Margin	38.96%	37.65%	36.36%	41.71%	36.97%	40.2%
Profit Margin	27.88%	1.66%	20.89%	16.83%	22.79%	0.49%
Free Cash Flow Margin	33.23%	35.83%	27.36%	30.58%	39.57%	30.45%
EBITDA	--	13,595	12,555	13,483	12,145	11,407
EBITDA Margin	--	47.28%	46.3%	49.42%	44.47%	46.2%
D&A For EBITDA	--	2,767	2,693	2,103	2,050	1,480
EBIT	11,333	10,828	9,862	11,380	10,095	9,927
EBIT Margin	38.96%	37.65%	36.36%	41.71%	36.97%	40.2%
Effective Tax Rate	17.96%	30.57%	18.18%	21.46%	25.09%	94.66%

Follow-Up Questions











